Voon Ong

1.4k total citations
40 papers, 1.0k citations indexed

About

Voon Ong is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Voon Ong has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Oncology. Recurrent topics in Voon Ong's work include Antifungal resistance and susceptibility (24 papers), Cancer Treatment and Pharmacology (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Voon Ong is often cited by papers focused on Antifungal resistance and susceptibility (24 papers), Cancer Treatment and Pharmacology (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Voon Ong collaborates with scholars based in United States, United Kingdom and Netherlands. Voon Ong's co-authors include Ronald A. Hites, Taylor Sandison, Dirk Thye, Ken Bartizal, Grayson Hough, Kenneth D. James, Lynn Miesel, Shawn D. Flanagan, Jeffrey B. Locke and Elizabeth A. Lakota and has published in prestigious journals such as Environmental Science & Technology, Blood and Analytical Chemistry.

In The Last Decade

Voon Ong

36 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Voon Ong United States	18	612	434	169	127	124	40	1.0k
Anna Karawajczyk Netherlands	15	828 1.4×	518 1.2×	530 3.1×	287 2.3×	157 1.3×	21	1.5k
Francisco Esteves Portugal	18	416 0.7×	521 1.2×	154 0.9×	35 0.3×	41 0.3×	34	952
Pascale Mauvais France	16	192 0.3×	293 0.7×	612 3.6×	95 0.7×	292 2.4×	26	1.3k
John Adamson South Africa	22	853 1.4×	613 1.4×	585 3.5×	36 0.3×	51 0.4×	34	1.5k
Nikolaus Schiering Switzerland	15	283 0.5×	114 0.3×	558 3.3×	60 0.5×	92 0.7×	22	1.4k
Jennifer Lynn Ford United States	19	330 0.5×	177 0.4×	370 2.2×	41 0.3×	67 0.5×	47	1.1k
Phyllis C. Braun United States	8	337 0.6×	276 0.6×	240 1.4×	106 0.8×	67 0.5×	13	777
Robin E. B. Lee United States	7	280 0.5×	169 0.4×	208 1.2×	81 0.6×	154 1.2×	8	533
V.B. Pikounis United States	6	519 0.8×	346 0.8×	210 1.2×	118 0.9×	88 0.7×	7	764

Countries citing papers authored by Voon Ong

Since Specialization

Citations

This map shows the geographic impact of Voon Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Voon Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Voon Ong more than expected).

Fields of papers citing papers by Voon Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Voon Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Voon Ong. The network helps show where Voon Ong may publish in the future.

Co-authorship network of co-authors of Voon Ong

This figure shows the co-authorship network connecting the top 25 collaborators of Voon Ong. A scholar is included among the top collaborators of Voon Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Voon Ong. Voon Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Locke, Jeffrey B., David R. Andes, Shawn D. Flanagan, et al.. (2025). Activity of rezafungin against Candida auris. Journal of Antimicrobial Chemotherapy. 80(6). 1482–1493.

Laenen, Annouschka, Grayson Hough, Jan Snoeys, et al.. (2025). Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of 14C-CD388 in the rat. Drug Metabolism and Disposition. 53(7). 100103–100103.

Andes, David R., Roger J. M. Brüggemann, Shawn D. Flanagan, et al.. (2024). The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics. Journal of Antimicrobial Chemotherapy. 80(1). 18–28. 7 indexed citations

Ong, Voon, et al.. (2024). Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(6). 435–443. 2 indexed citations

Ong, Voon, et al.. (2021). 982. Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin. Open Forum Infectious Diseases. 8(Supplement_1). S582–S583. 1 indexed citations

Ong, Voon, et al.. (2020). 1286. Pharmacokinetics, Excretion, and Mass Balance of [14C]-Rezafungin Following Intravenous (IV) Administration in Healthy Adults. Open Forum Infectious Diseases. 7(Supplement_1). S658–S659. 2 indexed citations

Bader, Justin, Elizabeth A. Lakota, Shawn D. Flanagan, et al.. (2018). Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata. Antimicrobial Agents and Chemotherapy. 62(6). 40 indexed citations

Flanagan, Shawn, Taylor Sandison, Jeffrey B. Locke, et al.. (2018). CD101 Prophylactic Dose Rationale for Prevention of Aspergillus, Candida, and Pneumocystis Infections. Biology of Blood and Marrow Transplantation. 24(3). S389–S390. 6 indexed citations

Zhao, Yanan, Winder B. Perez, Cristina Jiménez‐Ortigosa, et al.. (2016). CD101: a novel long‐acting echinocandin. Cellular Microbiology. 18(9). 1308–1316. 66 indexed citations

10.

Ong, Voon, Ken Bartizal, David Hughes, & Lynn Miesel. (2016). Efficacy of Topical CD101, a Novel Echinocandin, Against Azole-Resistant Candida albicans in Rat Vulvovaginal Candidiasis. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

11.

Lakota, Elizabeth A., Justin Bader, Dirk Thye, et al.. (2016). PK-PD Target Attainment Analyses to Support the Selection of Extended Interval CD101 Dosing Regimens. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

12.

Hilgers, M.T., Mark L. Cunningham, Bryan P. Kwan, et al.. (2014). Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2,4-diaminoquinazolines. Journal of Medicinal Chemistry. 57(3). 651–668. 66 indexed citations

13.

Malfatti, Michael, et al.. (2014). Use of Microdosing and Accelerator Mass Spectrometry To Evaluate the Pharmacokinetic Linearity of a Novel Tricyclic GyrB/ParE Inhibitor in Rats. Antimicrobial Agents and Chemotherapy. 58(11). 6477–6483. 5 indexed citations

14.

Ong, Voon, Shawn Flanagan, Edward Fang, et al.. (2014). Absorption, Distribution, Metabolism, and Excretion of the Novel Antibacterial Prodrug Tedizolid Phosphate. Drug Metabolism and Disposition. 42(8). 1275–1284. 62 indexed citations

15.

Nagasawa, Johnny, Jenny Z. Song, Huanming Chen, et al.. (2010). 6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(2). 760–763. 22 indexed citations

16.

Bhargava, Pankaj, John L. Marshall, Naiyer A. Rizvi, et al.. (1999). A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.. PubMed. 5(8). 1989–95. 120 indexed citations

17.

Ong, Voon, et al.. (1998). Quantitation of TNP-470 and its metabolites in human plasma: sample handling, assay performance and stability. Journal of Chromatography B Biomedical Sciences and Applications. 710(1-2). 173–182. 9 indexed citations

18.

Ong, Voon & Ronald A. Hites. (1995). Determination of Pesticides and Polychlorinated Biphenyls in Water: A Low-Solvent Method. Environmental Science & Technology. 29(5). 1259–1266. 19 indexed citations

19.

Ong, Voon & Ronald A. Hites. (1994). Electron capture mass spectrometry of organic environmental contaminants. Mass Spectrometry Reviews. 13(3). 259–283. 35 indexed citations

20.

Ong, Voon & Ronald A. Hites. (1993). Why are electron capture negative ion mass spectra not reproducible? An ion source problem. Journal of the American Society for Mass Spectrometry. 4(3). 270–277. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact